Joey jojo, that's why I added the article, discussing ADE.
In some cases, antibodies can enhance virus entry and replication in cells. This phenomenon is called antibody-dependent infection enhancement (ADE). ADE not only promotes the virus to be recognized by the target cell and enters the target cell, but also affects the signal transmission in the target cell. Early formalin-inactivated virus vaccines such as aluminum adjuvants (RSV and measles) have been shown to induce ADE. Although there is no direct evidence that there is ADE in COVID-19, this potential risk is a huge challenge for prevention and vaccine development.
The mechanism or interaction of ADE is not fully understood. It is necessary to understand the upstream and downstream molecular signal events of ADE. In the development of vaccines for a variety of viral diseases, ADE needs to be overcome.
Too put it in simple words, some vaccines facilitate virus transfer into
cells, that means helping along virus infection. So, instead of preventing
virus infection, some vaccines actually encouraged virus infection, e.g.,
Dengue and HIV. The Corona viruses are especially susceptible to this. Did they
allow time to test whether COVID vaccines will eventually go down this route?
How could they if they completed safety studies within two months? They also
did not have a control group (receiving the placebo) because in the end they
decided to vaccinate all participants in the study. And to press the
point, follow the rising VAERS numbers. More people are going to die from COVID
vaccines than COVID. Mark my words.